Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Cardiac Hypertrophy

triazoles has been researched along with Cardiac Hypertrophy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anand, P; Bradner, JE; Brown, JD; Duan, Q; Haldar, SM; Huang, Y; Lemieux, ME; McKinsey, TA; McMahon, S; Sahadevan, A; Salunga, HT; Shah, H; Srivastava, D; Thomas, S; Zhang, R1
Bradner, JE; Cavasin, MA; Demos-Davies, K; McKinsey, TA; Qi, J; Reid, BG; Spiltoir, JI; Stratton, MS1
Ares-Carrasco, S; Caro-Vadillo, A; Egido, J; Iborra, C; Lorenzo, O; Picatoste, B; Ramírez, E; Tuñón, J1
Abdullah, T; Baggio, LL; Bang, KW; Campbell, JE; Drucker, DJ; Mulvihill, EE; Ussher, JR; Varin, EM1
Ono, S; Voelkel, NF1

Other Studies

5 other study(ies) available for triazoles and Cardiac Hypertrophy

ArticleYear
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.
    Science translational medicine, 2017, 05-17, Volume: 9, Issue:390

    Topics: Animals; Azepines; Cardiomegaly; Gene Regulatory Networks; Heart Failure; Humans; Induced Pluripotent Stem Cells; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NF-kappa B; Proteins; Signal Transduction; Transforming Growth Factor beta; Triazoles

2017
BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2013, Volume: 63

    Topics: Animals; Azepines; Cardiomegaly; Carrier Proteins; Drug Discovery; High-Throughput Screening Assays; Models, Biological; Protein Binding; Rats; Triazoles

2013
Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Drug Evaluation, Preclinical; Fibroblasts; Fibronectins; Fibrosis; Glucagon-Like Peptide 1; Glucose Intolerance; Hypoglycemic Agents; Insulin; Male; Metformin; Myocardium; Myocytes, Cardiac; PPAR delta; Protein Isoforms; Pyrazines; Rats; Sitagliptin Phosphate; Triazoles

2013
Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
    Diabetes, 2016, Volume: 65, Issue:3

    Topics: Animals; Cardiomegaly; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fibrosis; Heart; Heart Failure; Hypoglycemic Agents; Immunoblotting; Inflammation; Liraglutide; Mice; Mice, Knockout; Myocardium; RNA, Messenger; Transcriptome; Triazoles; Ventricular Function; Ventricular Remodeling

2016
PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
    Journal of applied physiology (Bethesda, Md. : 1985), 1991, Volume: 71, Issue:6

    Topics: Animals; Azepines; Cardiomegaly; Hypertension, Pulmonary; Lung; Lung Injury; Male; Monocrotaline; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles

1991